Newsfeeds Archive - Spark Newswire

2 minute read

Labcorp’s Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal

April 25, 3:04 PM

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's specialty testing capabilities.

2 minute read

Softbank-Backed Cohesity To Acquire Veritas Data Security Unit For $3B: Report

By Benzinga Neuro

February 8, 5:34 AM

Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary of Carlyle Group.

ARM

3 minute read

US Stocks Gain; Uber Posts Upbeat Sales

By Avi Kapoor

February 7, 10:58 AM

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose 0.34% to 15,661.70. The S&P 500 also rose, gaining, 0.34% to 4,971.18.

GDTC

2 minute read

SoftBank-Backed Genetic Testing Invitae’s Descent from $7B Valuation to Near-Bankruptcy

By Vandana Singh

February 5, 2:23 PM

Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures.

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

February 5, 1:31 PM

Gainers 4D Molecular Therapeutics (NASDAQ:FDMT) stock increased by 75.2% to $30.64 during Monday’s regular session. The company’s market…

ADVM

1 minute read

‘Invitae Hires FTI, Kirkland & Ellis To Advise Options To Address $1.5B Of Debt As Company Prepares For Bankruptcy; Co Has Been Selling Assets To Shore Up Liquidity As Business Tanks’ – WSJ

By Benzinga Newsdesk

February 5, 12:12 PM

https://www.wsj.com/articles/softbank-backed-medical-genetics-company-invitae-prepares-for-bankruptcy-d468f120?st=02yzwzf1bnabmx0&mod=googlenewsfeed Invitae, a medical genetics company that received backing from

NVTA

2 minute read

Looking Into Invitae’s Recent Short Interest

By Benzinga Insights

January 18, 9:00 AM

Invitae’s (NYSE:NVTA) short percent of float has risen 6.1% since its last report. The company recently reported that…

NVTA

2 minute read

(NVTA) – Analyzing Invitae’s Short Interest

By Benzinga Insights

January 1, 2:15 PM

Invitae’s (NYSE:NVTA) short percent of float has risen 6.94% since its last report. The company recently reported that…

NVTA

2 minute read

US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit

By Vandana Singh

December 28, 1:57 PM

Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from

NEO

5 minute read

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

November 9, 2:13 PM

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

AFIB